1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
Oct 23, 2018•1 hr 3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations.
IMpassion130: doi.org/10.1056/NEJMoa1809615
Hot-spotting: https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast